Skip to main content
. Author manuscript; available in PMC: 2019 Aug 26.
Published in final edited form as: Ann Neurol. 2018 Aug 26;84(1):117–129. doi: 10.1002/ana.25274

TABLE 1.

Datasets Included in the Study

Dataset PD Patients Controls Genotyping Array
n Female, % Age at Onset, yr, Mean (SD) Diagnostic Criteria n Female, % Age at study, yr, Mean (SD)
Discovery
 IPDGC NeuroX28 5,542 35.5 61 (13) UKPDBB or neurologist diagnosis 5,866 44.2 64 (15) Illumina NeuroX
Replication
 phs000089.v3.p2, NINDS3 916 40.3 58 (13) UKPDBB 801 58.1 59 (16) Illumina HumanHap550 BeadChip
 phs000126.v1.p1, CIDR45 864 40.0 60 (16) Modified UKPDBBa 856 60.2 55 (13) Illumina HumanCNV370 BeadChip
 phs000196.v2.p1, NGRC9 1,972 32.4 58 (12) UKPDBB 1,984 61.3 70 (14) Illumina HumanOmni1_Quad
 Oslo46 474 36.3 56 (11) Modified UKPDBBa 464 42.5 62 (11) Illumina Infinium OmniExpress24
 PPMI47 314 32.2 60 (8) PPMI criteria 166 35.5 61 (11) Illumina NeuroX
 Finland48 386 45.9 55 (6) Neurologist diagnosis 493 78.9 92 (4) Illumina 660W or HumanCNV370 BeadChip
 Germany3 741 39.7 56 (12) UKPDBB 944 57.5 47 (12) Illumina HumanHap550 BeadChip
 Harvard Biomarker Study 541 34.6 66 (10) Neurologist diagnosis 473 61.7 79 (9) Illumina NeuroX
 Parkinson’s Disease Biomarker Program49 543 38.5 64 (9) Neurologist diagnosis 284 51.1 62 (11) Illumina NeuroX
 Spain50 210 35.2 67(11) UKPDBB 171 55.0 58 (14) Illumina NeuroX
Sum replication 6,961 6,636
Total 12,503 12,502

Age data were missing for 2% of patients and 0.3% of controls in the replication sample.

a

Modified UKPDBB criteria allow for affected first-degree relatives.

CIDR = Center for Inherited Disease Research; IPDGC = International Parkinson Disease Genomics Consortium; NGRC = NeuroGenetics Research Consortium; NINDS = National Institute of Neurological Disorders and Stroke; PD = Parkinson disease; PPMI = Parkinson’s Progression Marker Initiative; SD = standard deviation; UKPDBB = United Kingdom Parkinson’s Disease Brain Bank criteria.